These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15952174)

  • 1. Medium-sized peptides as built in carriers for biologically active compounds.
    Hudecz F; Bánóczi Z; Csík G
    Med Res Rev; 2005 Nov; 25(6):679-736. PubMed ID: 15952174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant fusion proteins TAT-Mu, Mu and Mu-Mu mediate efficient non-viral gene delivery.
    Rajagopalan R; Xavier J; Rangaraj N; Rao NM; Gopal V
    J Gene Med; 2007 Apr; 9(4):275-86. PubMed ID: 17397090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal peptide mimics conjugated to peptide nucleic acid: a promising solution for improving cell membrane permeability.
    Li X; Zhang L; Lu J; Chen Y; Min J; Zhang L
    Bioconjug Chem; 2003; 14(1):153-7. PubMed ID: 12526704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusion polypeptides that inhibit exocytosis: fusing aptamer and cell-penetrating peptide technologies and pharmacologies.
    Eiden LE
    Mol Pharmacol; 2005 Apr; 67(4):980-2. PubMed ID: 15673600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of cell-penetrating peptide-mediated peptide delivery.
    Jones SW; Christison R; Bundell K; Voyce CJ; Brockbank SM; Newham P; Lindsay MA
    Br J Pharmacol; 2005 Aug; 145(8):1093-102. PubMed ID: 15937518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular delivery of peptide nucleic acid by cell-penetrating peptides.
    Kilk K; Langel U
    Methods Mol Biol; 2005; 298():131-41. PubMed ID: 16044544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship study on a simple cationic peptide motif for cellular delivery of antisense peptide nucleic acid.
    Albertshofer K; Siwkowski AM; Wancewicz EV; Esau CC; Watanabe T; Nishihara KC; Kinberger GA; Malik L; Eldrup AB; Manoharan M; Geary RS; Monia BP; Swayze EE; Griffey RH; Bennett CF; Maier MA
    J Med Chem; 2005 Oct; 48(21):6741-9. PubMed ID: 16220989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of basic amphipathic peptides for cellular delivery of antisense peptide nucleic acids.
    Maier MA; Esau CC; Siwkowski AM; Wancewicz EV; Albertshofer K; Kinberger GA; Kadaba NS; Watanabe T; Manoharan M; Bennett CF; Griffey RH; Swayze EE
    J Med Chem; 2006 Apr; 49(8):2534-42. PubMed ID: 16610796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides.
    Gupta B; Levchenko TS; Torchilin VP
    Adv Drug Deliv Rev; 2005 Feb; 57(4):637-51. PubMed ID: 15722168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty acids can substitute the HIV fusion peptide in lipid merging and fusion: an analogy between viral and palmitoylated eukaryotic fusion proteins.
    Lev N; Shai Y
    J Mol Biol; 2007 Nov; 374(1):220-30. PubMed ID: 17919659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of linear, branched, and cyclic peptide chimera.
    Mezö G; Hudecz F
    Methods Mol Biol; 2005; 298():63-76. PubMed ID: 16044540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide-mediated cell transport of water soluble porphyrin conjugates.
    Sibrian-Vazquez M; Jensen TJ; Hammer RP; Vicente MG
    J Med Chem; 2006 Feb; 49(4):1364-72. PubMed ID: 16480271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrophobic substitutions in the first residue of the CRAC segment of the gp41 protein of HIV.
    Vishwanathan SA; Thomas A; Brasseur R; Epand RF; Hunter E; Epand RM
    Biochemistry; 2008 Jan; 47(1):124-30. PubMed ID: 18081318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular delivery of polyheteroaromate-peptide nucleic acid conjugates mediated by cationic lipids.
    Shiraishi T; Bendifallah N; Nielsen PE
    Bioconjug Chem; 2006; 17(1):189-94. PubMed ID: 16417268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly efficient, nonpeptidic oligoguanidinium vectors that selectively internalize into mitochondria.
    Fernández-Carneado J; Van Gool M; Martos V; Castel S; Prados P; de Mendoza J; Giralt E
    J Am Chem Soc; 2005 Jan; 127(3):869-74. PubMed ID: 15656624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hexapeptides that interfere with HIV-1 fusion peptide activity in liposomes block GP41-mediated membrane fusion.
    Gómara MJ; Lorizate M; Huarte N; Mingarro I; Perez-Payá E; Nieva JL
    FEBS Lett; 2006 May; 580(11):2561-6. PubMed ID: 16647705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.
    Münch J; Ständker L; Adermann K; Schulz A; Schindler M; Chinnadurai R; Pöhlmann S; Chaipan C; Biet T; Peters T; Meyer B; Wilhelm D; Lu H; Jing W; Jiang S; Forssmann WG; Kirchhoff F
    Cell; 2007 Apr; 129(2):263-75. PubMed ID: 17448989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravesical antisense therapy for cystitis using TAT-peptide nucleic acid conjugates.
    Tyagi P; Banerjee R; Basu S; Yoshimura N; Chancellor M; Huang L
    Mol Pharm; 2006; 3(4):398-406. PubMed ID: 16889433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrophobic alpha-helices 1 and 2 of herpes simplex virus gH interact with lipids, and their mimetic peptides enhance virus infection and fusion.
    Gianni T; Fato R; Bergamini C; Lenaz G; Campadelli-Fiume G
    J Virol; 2006 Aug; 80(16):8190-8. PubMed ID: 16873275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular protein delivery activity of peptides derived from insulin-like growth factor binding proteins 3 and 5.
    Goda N; Tenno T; Inomata K; Shirakawa M; Tanaka T; Hiroaki H
    Exp Cell Res; 2008 Aug; 314(13):2352-61. PubMed ID: 18602100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.